News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
352,924 Results
Type
Article (16441)
Company Profile (332)
Press Release (336151)
Section
Business (106504)
Career Advice (295)
Deals (18457)
Drug Delivery (38)
Drug Development (55415)
Employer Resources (46)
FDA (7830)
Job Trends (7304)
News (185795)
Policy (13864)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
Academia (1277)
Accelerated approval (2)
Adcomms (12)
Allergies (53)
Alliances (30506)
ALS (66)
Alzheimer's disease (957)
Antibody-drug conjugate (ADC) (89)
Approvals (7864)
Artificial intelligence (142)
Autoimmune disease (10)
Automation (8)
Bankruptcy (130)
Best Places to Work (6436)
BIOSECURE Act (8)
Biosimilars (53)
Biotechnology (265)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (166)
Cancer (1461)
Cardiovascular disease (110)
Career advice (253)
Career pathing (5)
CAR-T (115)
Cell therapy (326)
Cervical cancer (9)
Clinical research (45115)
Collaboration (618)
Compensation (254)
Complete response letters (13)
COVID-19 (1176)
CRISPR (36)
C-suite (172)
Cystic fibrosis (83)
Data (1464)
Denatured (11)
Depression (31)
Diabetes (140)
Diagnostics (2616)
Digital health (6)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (83)
Drug pricing (30)
Drug shortages (3)
Duchenne muscular dystrophy (82)
Earnings (37602)
Editorial (18)
Employer branding (8)
Employer resources (40)
Events (59199)
Executive appointments (512)
FDA (8601)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (576)
Gene editing (88)
Generative AI (11)
Gene therapy (248)
GLP-1 (390)
Government (1491)
Grass and pollen (2)
Guidances (24)
Healthcare (9804)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (84)
Indications (22)
Infectious disease (1249)
Inflammatory bowel disease (118)
Inflation Reduction Act (8)
Influenza (24)
Intellectual property (62)
Interviews (46)
IPO (9002)
IRA (12)
Job creations (1208)
Job search strategy (228)
Kidney cancer (6)
Labor market (5)
Layoffs (224)
Leadership (3)
Legal (2427)
Liver cancer (44)
Lung cancer (206)
Lymphoma (90)
Machine learning (1)
Management (12)
Manufacturing (149)
MASH (51)
Medical device (5215)
Medtech (5218)
Mergers & acquisitions (9846)
Metabolic disorders (391)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (60)
Neuropsychiatric disorders (23)
Neuroscience (1348)
NextGen: Class of 2025 (3256)
Non-profit (2449)
Northern California (1747)
Now hiring (21)
Obesity (196)
Opinion (116)
Ovarian cancer (64)
Pain (47)
Pancreatic cancer (61)
Parkinson's disease (110)
Partnered (8)
Patents (125)
Patient recruitment (73)
Peanut (35)
People (33639)
Pharmaceutical (59)
Pharmacy benefit managers (5)
Phase I (15413)
Phase II (20648)
Phase III (13786)
Pipeline (766)
Podcasts (46)
Policy (42)
Postmarket research (1081)
Preclinical (6413)
Press Release (50)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (224)
Rare diseases (289)
Real estate (2387)
Recruiting (16)
Regulatory (11149)
Reports (18)
Research institute (1356)
Resumes & cover letters (33)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (56)
Series A (117)
Series B (72)
Service/supplier (3)
Sickle cell disease (38)
Southern California (1565)
Special edition (11)
Spinal muscular atrophy (120)
Sponsored (13)
Startups (2430)
State (2)
Stomach cancer (4)
Supply chain (23)
The Weekly (33)
United States (14398)
Vaccines (258)
Venture capitalists (31)
Webinars (7)
Weight loss (107)
Women's health (20)
Worklife (5)
Date
Today (11)
Last 7 days (419)
Last 30 days (1851)
Last 365 days (23819)
2025 (5487)
2024 (24686)
2023 (27302)
2022 (33821)
2021 (35369)
2020 (31441)
2019 (24417)
2018 (17768)
2017 (17840)
2016 (15963)
2015 (19082)
2014 (13926)
2013 (10483)
2012 (10572)
2011 (10838)
2010 (9946)
Location
Africa (248)
Alabama (43)
Alaska (4)
Arizona (81)
Arkansas (12)
Asia (31339)
Australia (4467)
California (4026)
Canada (1205)
China (393)
Colorado (156)
Connecticut (185)
Delaware (90)
Europe (48109)
Florida (518)
Georgia (133)
Idaho (27)
Illinois (277)
India (12)
Indiana (121)
Iowa (5)
Japan (114)
Kansas (71)
Kentucky (9)
Louisiana (4)
Maine (14)
Maryland (557)
Massachusetts (3164)
Michigan (91)
Minnesota (192)
Mississippi (1)
Missouri (53)
Montana (26)
Nebraska (14)
Nevada (24)
New Hampshire (42)
New Jersey (1047)
New Mexico (18)
New York (1095)
North Carolina (652)
North Dakota (6)
Northern California (1747)
Ohio (134)
Oklahoma (12)
Oregon (24)
Pennsylvania (772)
Puerto Rico (4)
Rhode Island (18)
South America (341)
South Carolina (10)
Southern California (1565)
Tennessee (57)
Texas (496)
Utah (98)
Virginia (85)
Washington D.C. (34)
Washington State (370)
West Virginia (2)
Wisconsin (26)
352,924 Results for "mission therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pipeline
Mission Nixes Preclinical Studies, Falls Back on Clinical Candidates
Mission Therapeutics is down to its clinical assets MTX652 and MTX325, which work by disabling a key enzyme that interferes with the cell’s normal process of removing faulty or dysfunctional mitochondria.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer
March 11, 2025
·
3 min read
Press Releases
Photys Therapeutics Enters into Exclusive License Agreement with Polymed for Phase 1-Ready IRAK4 Degrader, Furthering its Proximity-based Pipeline and Mission
February 20, 2025
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
March 26, 2025
·
10 min read
Press Releases
Biophytis Announces New Non-Clinical Data Further Supporting Its Mission to Pioneer the Restoration of Mobility in Patients with Obesity
March 24, 2025
·
4 min read
Recce Pharmaceuticals Selected by UK Government Innovation Agency to Participate in AMR Mission 2024
Recce Pharmaceuticals Ltd, the Company developing a new class of synthetic anti-infectives, announced its selection by the United Kingdom’s Government Innovation Agency to partake in the prestigious UK Antimicrobial Resistance Inward Mission 2024.
April 9, 2024
·
4 min read
Press Releases
Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd
December 18, 2024
·
4 min read
Press Releases
Kestra Medical Technologies, Ltd. Appoints Neil Bhalodkar as Vice President of Investor Relations
February 26, 2025
·
1 min read
Press Releases
Oranda Therapeutics Announces Series A Funding Round to support its mission: to improve the lives of patients living with rare disease
November 12, 2024
·
3 min read
1 of 35,293
Next
